AllianceBernstein’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$819K	Hold	49,390	–	–	﹤0.01%	2424
2025 Q4	$819K	Buy	49,390 +3,800	+8%	+$54.3K	﹤0.01%	2434
2025 Q3	$537K	Sell	45,590 -5,000	-10%	-$51.6K	﹤0.01%	2637
2025 Q2	$485K	Buy	50,590 +5,000	+11%	+$27.7K	﹤0.01%	2653
2025 Q1	$286K	Hold	45,590	–	–	﹤0.01%	2794
2024 Q4	$370K	Sell	45,590 -4,520	-9%	-$56K	﹤0.01%	2776
2024 Q3	$906K	Hold	50,110	–	–	﹤0.01%	2370
2024 Q2	$516K	Buy	50,110 +17,820	+55%	+$184K	﹤0.01%	2653
2024 Q1	$343K	Sell	32,290 -5,410	-14%	-$45.9K	﹤0.01%	2758
2023 Q4	$344K	Hold	37,700	–	–	﹤0.01%	2782
2023 Q3	$391K	Hold	37,700	–	–	﹤0.01%	2697
2023 Q2	$540K	Buy	37,700 +10,400	+38%	+$120K	﹤0.01%	2595
2023 Q1	$195K	Buy	27,300 +4,800	+21%	+$42.2K	﹤0.01%	2914
2022 Q4	$252K	Buy	22,500 +6,700	+42%	+$69.1K	﹤0.01%	2924
2022 Q3	$175K	Buy	15,800 +1,200	+8%	+$11.4K	﹤0.01%	3047
2022 Q2	$123K	Buy	14,600 +2,900	+25%	+$29.8K	﹤0.01%	3102
2022 Q1	$159K	Sell	11,700 -1,200	-9%	-$19.4K	﹤0.01%	3041
2021 Q4	$254K	Buy	12,900 +1,900	+17%	+$44.7K	﹤0.01%	2994
2021 Q3	$353K	Sell	11,000 -1,300	-11%	-$43.2K	﹤0.01%	2904
2021 Q2	$416K	Buy	12,300 +1,800	+17%	+$64.5K	﹤0.01%	2891
2021 Q1	$394K	Sell	10,500 -900	-8%	-$37.7K	﹤0.01%	2778
2020 Q4	$379K	Sell	11,400 -700	-6%	-$28.4K	﹤0.01%	2733
2020 Q3	$444K	Sell	12,100 -1,900	-14%	-$65.8K	﹤0.01%	2580
2020 Q2	$461K	Buy	+14,000	New	+$538K	﹤0.01%	2666